Ivan Talucciπ£ Happy to share our recent research featured in Neurology "Glycine Receptor Ξ²βTargeting Autoantibodies Contribute to Autoimmune Disease Pathology" The Array fine mapped #2 GlyR Beta autoantibodies, both capable of impair glycine efficacy π¬π¨βπ¬
https://doi.org/10.1212/NXI.0000000000200187
Great work in Collaboration with the Villmann Group, spearheaded by Anna-Lena.
